CIK 0001631574 · Large accelerated filer
Wave Life Sciences, Inc.
Sign in to watch- Ticker
- WVE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 617-949-2900
- Business address
- 733 CONCORD AVENUE, CAMBRIDGE, MA, 02138
- Former names
- Wave Life Sciences Ltd., Wave Life Sciences LTD., WAVE Life Sciences Ltd., Wave Life Sciences Pte Ltd
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-02-17 | Moran Kyle Chief Financial Officer | Grant or award · Share Option (right to buy) | +272,700 | 272,700 | ||
| 2023-02-16 | Vargeese Chandra See Remarks | Sale | −10,249 | $4.03 | $41K | 106,624 |
| 2023-02-16 | BOLNO PAUL President and CEO | Sale | −29,400 | $4.04 | $119K | 407,425 |
| 2023-02-16 | Francis Chris See Remarks | Sale | −10,258 | $4.03 | $41K | 79,714 |
| 2023-02-16 | Moran Kyle Chief Financial Officer | Sale | −9,729 | $4.04 | $39K | 79,751 |
| 2022-10-27 | Verdine Gregory L. Director | Grant or award · Share Option (right to buy) | +163,467 | 163,467 | ||
| 2022-08-15 | RA CAPITAL MANAGEMENT, L.P. Director | Grant or award · Share Option (right to buy) | +21,000 | 21,000 | ||
| 2022-08-15 | Rawcliffe Adrian Director | Grant or award · Share Option (right to buy) | +21,000 | 21,000 | ||
| 2022-08-15 | HENRY CHRISTIAN O Director | Grant or award · Share Option (right to buy) | +21,000 | 21,000 | ||
| 2022-08-15 | Verdine Gregory L. Director | Grant or award · Share Option (right to buy) | +21,000 | 21,000 | ||
| 2022-08-15 | Wagner Heidi L Director | Grant or award · Share Option (right to buy) | +21,000 | 21,000 | ||
| 2022-08-15 | TAKANASHI KEN Director | Grant or award · Share Option (right to buy) | +21,000 | 21,000 | ||
| 2022-08-15 | CORRIGAN MARK Director | Grant or award · Share Option (right to buy) | +21,000 | 21,000 | ||
| 2022-08-15 | Tan Aik Na Director | Grant or award · Share Option (right to buy) | +21,000 | 21,000 | ||
| 2022-07-25 | Moran Kyle Chief Financial Officer | Grant or award · Share Option (right to buy) | +60,000 | 60,000 |
Page 13 of 13 · 255 trades